FRED ALGER MANAGEMENT, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 3520 NEW YORK, NY

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$269,139,417

+$59,565,106 QoQ

Shares Held

3,301,919

-1.2% QoQ

Ownership

2.34%

of shares outstanding

% of Portfolio

0.90%

of 13F equity value

Holder Rank

#10

of 496 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names. ARWR ranks #1 (36.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc. This page	3,301,919	$269,139,417
2	DNTH	Dianthus Therapeutics, Inc. /DE/	1,302,493	$126,967,017
3	RVMD	Revolution Medicines, Inc.	259,468	$48,593,167
4	ASND	Ascendis Pharma A/S	171,447	$45,728,343
5	COGT	Cogent Biosciences, Inc.	1,072,830	$41,518,521
6	ROIV	Roivant Sciences Ltd.	1,081,421	$38,271,489
7	FBRX	Forte Biosciences, Inc.	1,439,697	$30,593,561
8	ERAS	Erasca, Inc.	1,308,455	$23,970,895

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$269,139,417	3,301,919	-1.2%	Shares	Sole	2026-08-14
2026-03-31	$209,574,311	3,342,493	+82.4%	Shares	Sole	2026-05-15
2025-12-31	$121,692,670	1,832,997	+497.4%	Shares	Sole	2026-02-17
2025-09-30	$10,582,670	306,833	+19785.5%	Shares	Sole	2025-11-14
2024-03-31	$44,129	1,543	-96.0%	Shares	Sole	2024-05-15
2023-12-31	$1,182,261	38,636	-16.8%	Shares	Sole	2024-02-14
2023-09-30	$1,247,278	46,419	-72.2%	Shares	Sole	2023-11-14
2023-06-30	$5,957,181	167,055	+299.6%	Shares	Sole	2023-08-14
2021-09-30	$2,609,761	41,803	+57.4%	Shares	Sole	2021-11-15
2021-06-30	$2,199,202	26,554	-15.1%	Shares	Sole	2021-08-16
2021-03-31	$2,073,712	31,273	-11.5%	Shares	Sole	2021-05-17
2020-12-31	$2,710,180	35,321	+341.5%	Shares	Sole	2021-02-16
2020-03-31	$230,160	8,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.